932 related articles for article (PubMed ID: 24334871)
1. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
2. Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.
Mouraret N; Marcos E; Abid S; Gary-Bobo G; Saker M; Houssaini A; Dubois-Rande JL; Boyer L; Boczkowski J; Derumeaux G; Amsellem V; Adnot S
Circulation; 2013 Apr; 127(16):1664-76. PubMed ID: 23513067
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
[TBL] [Abstract][Full Text] [Related]
4. New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
Abid S; Kebe K; Houssaïni A; Tomberli F; Marcos E; Bizard E; Breau M; Parpaleix A; Tissot CM; Maitre B; Lipskaia L; Derumeaux G; Bastia E; Mekontso-Dessap A; Adnot S
J Cardiovasc Pharmacol; 2018 May; 71(5):283-292. PubMed ID: 29438213
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
[TBL] [Abstract][Full Text] [Related]
7. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
8. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
9. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
Paffett ML; Lucas SN; Campen MJ
Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
[TBL] [Abstract][Full Text] [Related]
11. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
[TBL] [Abstract][Full Text] [Related]
12. Role for telomerase in pulmonary hypertension.
Mouraret N; Houssaïni A; Abid S; Quarck R; Marcos E; Parpaleix A; Gary-Bobo G; Dubois-Randé JL; Derumeaux G; Boczkowski J; Delcroix M; Blasco MA; Lipskaia L; Amsellem V; Adnot S
Circulation; 2015 Feb; 131(8):742-755. PubMed ID: 25550449
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.
Wang J; Chen Y; Lin C; Jia J; Tian L; Yang K; Zhao L; Lai N; Jiang Q; Sun Y; Zhong N; Ran P; Lu W
Am J Physiol Cell Physiol; 2014 Feb; 306(4):C364-73. PubMed ID: 24336649
[TBL] [Abstract][Full Text] [Related]
14. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.
Saker M; Lipskaia L; Marcos E; Abid S; Parpaleix A; Houssaini A; Validire P; Girard P; Noureddine H; Boyer L; Vienney N; Amsellem V; Marguerit L; Maitre B; Derumeaux G; Dubois-Rande JL; Jourdan-Lesaux C; Delcroix M; Quarck R; Adnot S
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1879-90. PubMed ID: 27444202
[TBL] [Abstract][Full Text] [Related]
17. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
